For example, Nagai et al. [69] have demonstrated that sorafenib is able to suppress hepatocyte growth factor-induced liver cancer cell EMT by downregulation of Snail expression through blockage of the RAS/RAF/MEK signaling pathway. This evidence concerns the gene MAP2K7 and liver cancer.